Development of a Canadian Guidance for reporting real-world evidence for regulatory and health-technology assessment (HTA) decision-making

Mina Tadrous*, Theresa Aves, Christine Fahim, Jessica Riad, Nicole Mittmann, Daniel Prieto-Alhambra, Donna R. Rivera, Kelvin Chan, Lisa M. Lix, Seamus Kent, Dalia Dawoud, Jason Robert Guertin, James Ted McDonald, Jeff Round, Scott Klarenbach, Sanja Stanojevic, Mary A. De Vera, Erin Strumpf, Robert W. Platt, Farah HuseinLaurie Lambert, Kaleen N. Hayes

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

6 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Development of a Canadian Guidance for reporting real-world evidence for regulatory and health-technology assessment (HTA) decision-making'. Together they form a unique fingerprint.

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science